Junín virus infects mouse cells and induces innate immune responses

Journal of Virology

Volumn 85, Issue 21, 2011, Pages 11058-11068

  Cuevas, Christian D ^a   Lavanya, Madakasira ^a   Wang, Enxiu ^a,b   Ross, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; TOLL LIKE RECEPTOR 2; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS GLYCOPROTEIN; CYTOKINE; VIRUS RECEPTOR;

ANIMAL CELL; ARGENTINE HEMORRHAGIC FEVER; ARTICLE; BIOSENSOR; CANDID 1 VIRUS; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INNATE IMMUNITY; JUNIN VIRUS; MACROPHAGE; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS LIKE AGENT; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MOUSE;

CALOMYS MUSCULINUS; CANDIDA; JUNIN VIRUS; RODENTIA;

ANIMALS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; JUNIN VIRUS; MICE; RECEPTORS, VIRUS; TOLL-LIKE RECEPTOR 2; VIRUS INTERNALIZATION;

EID: 80055115680     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05304-11     Document Type: Article

References (60)

1. Abraham, J., K. D. Corbett, M. Farzan, H. Choe, and S. C. Harrison 2010. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat. Struct. Mol. Biol. 17:438-444.
2. Abraham, J., et al 2009. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic New World clade B arenaviruses. PLoS Pathog. 5:e1000358.
3. Adachi, O., et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.
4. Albarino, C. G., et al 2009. Efficient reverse genetics generation of infectious Junin viruses differing in glycoprotein processing. J. Virol. 83:5606-5614.
5. Albarino, C. G., et al 2011. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemmorhagic fever is located in the G2 glycoprotein transmembrane domain. J. Virol. 85:10404-10408.
6. Albarino, C. G., et al 2011. Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domains. J. Virol. 85:112-122.
7. Albarino, C. G., et al. 1997. Molecular characterization of attenuated Junin virus strains. J. Gen. Virol. 78:1605-1610.
8. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell 2001. Recognition of double-stranded RNA and activation of NF-_B by Toll-like receptor Nature 413:732-738.
9. Avila, M. M., R. M. Laguens, R. P. Laguens, and M. C. Weissenbacher. 1981. Tissue selectivity and virulence indicators of 3 strains of Junin virus. Medicina (B. Aires) 41:157-166. (In Spanish.)
10. Bieback, K., et al 2002. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76:8729-8736.
11. Boehme, K. W., J. Singh, S. T. Perry, and T. Compton 2004. Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J. Virol. 78:1202-1211.
12. Caamano, J., J. Alexander, L. Craig, R. Bravo, and C. A. Hunter. 1999. The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:4453-4461.
13. Castilla, V., L. M. Palermo, and C. E. Coto 2001. Involvement of vacuolar proton ATPase in Junin virus multiplication. Arch. Virol. 146:251-263.
14. Charrel, R. N., and X. de Lamballerie 2003. Arenaviruses other than Lassa virus. Antiviral Res. 57:89-100.
15. Choe, H., S. Jemielity, J. Abraham, S. R. Radoshitzky, and M. Farzan 2011. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Curr. Opin. Microbiol. 14:1-7.
16. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa 2004. Innate antiviral responses by mean of TLR7-mediated recognition of singlestranded RNA. Science 303:1529-1531.
17. Dortmans, J. C., P. J. Rottier, G. Koch, and B. P. Peeters 2010. The viral replication complex is associated with the virulence of Newcastle disease virus. J. Virol. 84:10113-10120.
18. Enria, D. A., A. M. Briggiler, and Z. Sanchez 2008. Treatment of Argentine hemorrhagic fever. Antiviral Res. 78:132-139.
19. Fan, L., T. Briese, and W. I. Lipkin 2010. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J. Virol. 84:1785-1791.
20. Flanagan, M. L., et al 2008. New World Clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J. Virol. 82:938-948.
21. Geisbert, T. W., and P. B. Jahrling 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10:S110-S121.
22. Georgel, P., et al 2007. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362:304-313.
23. Gomez, R. M., et al 2011. Junin virus. A XXI century update. Microbes Infect. 13:303-311.
24. Goni, S. E., et al 2006. Genomic features of attenuate Junin virus vaccine strain candidate. Virus Genes 32:37-41.
25. Goni, S. E., et al 2010. Molecular analysis of the virulence attenuation process in Junin virus vaccine genealogy. Virus Genes 40:320-328.
26. Goni, S. E., et al 2011. Viral diversity of Junin virus field strains. Virus Res. 160:150-158.
27. Gonzalez, P. H., P. M. Cossio, R. Arana, J. I. Maiztegui, and R. P. Laguens. 1980. Lymphatic tissue in Argentine hemorrhagic fever. Pathologic features. Arch. Pathol. Lab. Med. 104:250-254.
28. Groseth, A., et al 2011. Tacaribe virus but not Junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Negl. Trop. Dis. 5:e1137.
29. Groseth, A., S. Wolff, T. Strecker, T. Hoenen, and S. Becker 2010. Efficient budding of the tacaribe virus matrix protein Z requires the nucleoprotein. J. Virol. 84:3603-3611.
30. Heller, M. V., M. C. Saavedra, R. Falcoff, J. I. Maiztegui, and F. C. Molinas. 1992. Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever. J. Infect. Dis. 166:1203-1204.
31. Kato, H., et al 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
32. Kolokoltsova, O. A., et al 2010. Mice lacking alpha/beta and gamma interferon receptors are susceptible to Junin virus infection. J. Virol. 84:13063-13067.
33. Kovacsovics, M., et al 2002. Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation. Curr. Biol. 12:838-843.
34. Kunz, S 2009. Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction. Virology 387:245-249.
35. Kurt-Jones, E. A., et al 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401.
36. Laguens, M., J. G. Chambo, and R. P. Laguens. 1983. In vivo replication of pathogenic and attenuated strains of Junin virus in different cell populations of lymphatic tissue. Infect. Haemost. 41:1279-1283.
37. Levis, S. C., et al. 1985. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 5:383-389.
38. Lucas, M., et al 2007. Tracking virus-specific CD4_ T cells during and after acute hepatitis C virus infection. PLoS One 2:e649.
39. Marta, R. F., et al. 1999. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 60:85-89.
40. Martinez-Sobrido, L., P. Giannakas, B. Cubitt, A. Garcia-Sastre, and J. C. de la Torre 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81:12696-12703.
41. Martinez-Sobrido, L., E. I. Zuniga, D. Rosario, A. Garcia-Sastre, and J. C. de la Torre 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80:9192-9199.
42. Meylan, E., and J. Tschopp 2006. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22:561-569.
43. Oldenburg, J., T. Reignier, M. L. Flanagan, G. A. Hamilton, and P. M. Cannon 2007. Differences in tropism and pH dependence for glycoproteins from the clade B1 arenaviruses: implications for receptor usage and pathogenicity. Virology 364:132-139.
44. Radoshitzky, S. R., et al 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96.
45. Radoshitzky, S. R., et al 2008. Receptor determinants of zoonotic transmission of new world hemorrhagic fever arenaviruses. Proc. Natl. Acad. Sci. U. S. A. 105:2664-2669.
46. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A. 99:2281-2286.
47. Reignier, T., et al 2006. Receptor use by pathogenic arenaviruses. Virology 353:111-120.
48. Reske, A., G. Pollara, C. Krummenacher, D. R. Katz, and B. M. Chain 2008. Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J. Immunol. 180:7525-7536.
49. Ross, S. R., J. J. Schofield, C. J. Farr, and M. Bucan 2002. Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus. Proc. Natl. Acad. Sci. U. S. A. 99:12386-12390.
50. Sato, S., et al 2000. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165:7096-7101.
51. Schoenemeyer, A., et al 2005. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J. Biol. Chem. 280:17005-17012.
52. Smelt, S. C., et al 2001. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J. Virol. 75:448-457.
53. Soneoka, Y., et al. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
54. Takeda, M., et al. 1998. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72:8690-8696.
55. Takeuchi, O., et al. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
56. U.S. Department of Health and Human Services 2007. HHS public health emergency medical countermeasure enterprise implementation plan for chemical, biological, radiological and nuclear threats. U.S. Department of Health and Human Services, Washington, DC.
57. York, J., and J. H. Nunberg 2006. Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion. J. Virol. 80:7775-7780.
58. Zhou, S., et al 2010. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 84: 9452-9462.
59. Zhou, S., et al 2008. Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J. Neuroimmunol. 194:70-82.
60. Zhou, S., et al 2005. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35:822-830.